来自MSN

Using GLP-1s for MASH: Dos and don’ts

If your doctor recommended you start taking a glucagon-like peptide-1 (GLP-1) receptor agonist like semaglutide to help manage your metabolic dysfunction-associated steatohepatitis (MASH), you likely ...
Newsweek

Cleveland Clinic Is Reversing Type 2 Diabetes—With AI, Not GLP-1s

Five years after her type 2 diabetes diagnosis, Deb Biller was running out of options. Biller knew that her glucose levels had been rising at each yearly check-up with her primary care physician (PCP) ...
Las Vegas Sun

Dewey Decimal System still most common, but some libraries using updated classification

Editor’s note: “Behind the News” is the product of Sun staff assisted by the Sun’s AI lab, which includes a variety of tools such as Anthropic’s Claude, Perplexity AI, Google Gemini and ChatGPT. Dewey ...
GitHub

Improving Diffusion Models for Inverse Problems Using Optimal Posterior Covariance

Abstract: Recent diffusion models provide a promising zero-shot solution to noisy linear inverse problems without retraining for specific inverse problems. In this paper, we reveal that recent methods ...
gastroenterologyadvisor

GLP-1s Hold Promise as Treatment for Tobacco/Nicotine Use Disorder

Illustration courtesy of Vivian Chang This 3-part series looks at the current evidence for the treatment of SUDs. Part 3 reviews the use of GLP-1 receptor agonists and tobacco use. A variety of ...